Inflammatory Myopathies Flashcards
Dermatomyositis, polymyositis, and inclusion body myositis are all examples of ___
inflammatory myopathies
How common are inflammatory myopathies?
Uncommon, 1 in 100,000 annually
Are inflammatory myopathies suppurative?
Nonsuppurative inflammation
Inflammatory myopathies have what four characteristics?
- Presence of inflammatory cells
- Necrosis and phagocytosis of muscle fibers
- A mixture of regenerating and atrophic fibers
- Fibrosis
Which muscles commonly experience weakness with inflammatory myopathies?
Symmetrical proximal muscles (shoulders, hips, torso) (can eventually go distal)
How do inflammatory myopathy symptoms progress over time?
Gradually increasing symptoms over weeks or months
Progressive difficulties with activities of daily living (lifting object, climbing stairs, combing hair, holding head up)
Inflammatory myopathy lab results show increased ___
- serum muscle-derived enzymes
- ESR
- (maybe) C-reactive protein
Inflammatory myopathies are commonly comorbid with ___
other autoimmune conditions (antibodies tested to determine which)
How are inflammatory myopathies generally treated?
Autoimmune treatments:
- Corticosteroids
- Immunosuppressant drugs (DMARDs) or IV immunoglobulin
Which inflammatory myopathy has no effective therapy?
Inclusion body myositis
Does dermatomyositis more often affect children or adults?
Adults
Dermatomyositis is likely comorbid with ___
systemic sclerosis or other autoimmune disorders
A patient presents with a rash on their upper eyelids, face, trunk, and some other areas. It is known that this patient has systemic sclerosis, but now there is evidence of necrosis of skeletal muscle tissue and fiber atrophy.
What is the likely diagnosis?
Dermatomyositis
What is the etiology of dermatomyositis?
Autoimmune
With dermatomyositis, compliment mediated (humoral immunity) antibodies attack ___ of skeletal muscle
microvasculature
angiopathy, microvasculitis
With dermatomyositis, ___ attack microvasculature of skeletal muscle (angiopathy)
compliment mediated antibodies (humoral immunity)